Spectrum Pharmaceuticals (SPPI) 10-Q2018 Q1 Quarterly report

Filed: 4 May 18, 5:01pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: aforementioned, alternative, American, announced, basket, biopharma, carryforward, CEO, CFO, choice, choose, circumvent, cohort, commonly, Conference, confirmed, constrained, constraint, COO, correct, correction, death, deemed, disability, Duration, embedded, emtansine, enforceable, engineered, error, explicitly, extend, forward, gather, genetically, GMT, hat, highlighting, inception, incomplete, inseparable, irreversible, kinase, lived, long, mandatory, meaningful, median, Medicine, mouse, multiplied, mutant, outflow, payroll, pegfilgrastim, persisted, perspective, physical, pocket, poor, poster, precisely, preclinical, profile, proforma, provisional, published, qualitative, quantitative, rare, redemption, refundable, repatriation, repurchase, reset, rigid, SAB, satisfied, satisfy, serve, silico, small, steric, survival, taxable, taxation, taxpayer, Toronto, tumor, tyrosine, unlimited, upcoming, vitro, vivo, worth, xenograft

Removed: accomplished, achieving, ANDA, assured, BLA, bundle, candidate, carryover, classify, commensurate, compound, core, CTI, deduction, deferral, deliverable, detail, determinable, determining, Direct, dividend, dollar, element, exist, expire, finally, forthcoming, governmental, inability, indirect, instance, intention, intra, National, OncoVenture, ordered, package, persuasive, preferred, principle, prophylactic, prospectively, PTCL, rated, recognizing, reoccur, resale, resolved, seeking, shareholder, shipped, standalone, substantial, title, unearned, unrealizable, voting

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated SPPI transcripts

SPPI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, Kurt A. Gustafson, certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that, to my knowledge, the Quarterly Report of Spectrum Pharmaceuticals, Inc. on Form 10-Q for the quarterly period ended March 31, 2018 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents in all material respects the financial condition and results of operations of Spectrum Pharmaceuticals, Inc.



Date:	May 4, 2018	By:	/s/ Kurt A. Gustafson
		Name:	Kurt A. Gustafson
		Title:	Executive Vice President and Chief Financial Officer

This certification accompanies the Report pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities and Exchange Act of 1934, or otherwise subject to the liability of that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, or, the Securities Exchange Act of 1934, except to the extent that the Company specifically incorporated by reference.